Cargando…

Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens

Host immune responses play an important role in the outcome of infection with hepatitis C virus (HCV). They can lead to viral clearance and a positive outcome, or progression and severity of chronic disease. Extensive research in the past >25 years into understanding the immune responses against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Babita, Gupta, Nancy, Vedi, Satish, Singh, Shakti, Li, Wen, Garg, Saurabh, Li, Jie, Kumar, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562520/ https://www.ncbi.nlm.nih.gov/pubmed/31130710 http://dx.doi.org/10.3390/cells8050507

Ejemplares similares

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines
por: Singh, Shakti, et al.
Publicado: (2016)

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
por: Agrawal, Babita, et al.
Publicado: (2017)

Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes
por: Guan, Jie, et al.
Publicado: (2011)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic
por: Gupta, Nancy, et al.
Publicado: (2023)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector
por: Lebedeva, Ekaterina, et al.
Publicado: (2018)

Adenovirus-vectored novel African Swine Fever Virus antigens elicit robust immune responses in swine
por: Lokhandwala, Shehnaz, et al.
Publicado: (2017)

Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors
por: Bontkes, Hetty J., et al.
Publicado: (2005)

Dose Effects of Recombinant Adenovirus Immunization in Rodents
por: Weaver, Eric A.
Publicado: (2019)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2019)

Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay
por: Hadziyannis, Emilia, et al.
Publicado: (2013)

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2012)

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
por: Gupta, Nancy, et al.
Publicado: (2018)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022)

Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020)

Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route
por: Carey, John B., et al.
Publicado: (2014)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2023)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity
por: Song, Wenru, et al.
Publicado: (1997)

Sexual Transmission of HCV in Heterologous Monogamous Spouses
por: Rafik, Mona M., et al.
Publicado: (2014)

The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response
por: Muñoz de Rueda, P., et al.
Publicado: (2017)

An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA
por: Hansoongnern, Payuda, et al.
Publicado: (2023)

Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli
por: Hoffmann, Dennis, et al.
Publicado: (2006)

Immunization of pigs with replication-incompetent adenovirus-vectored African swine fever virus multi-antigens induced humoral immune responses but no protection following contact challenge
por: Zajac, Michelle D., et al.
Publicado: (2023)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm
por: Aldhamen, Yasser Ali, et al.
Publicado: (2011)

Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses
por: Machitani, Mitsuhiro, et al.
Publicado: (2011)

HCV Innate Immune Responses
por: Heim, Markus H.
Publicado: (2009)

A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients
por: Shen, Tao, et al.
Publicado: (2011)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
por: Agrawal, Babita
Publicado: (2019)

Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study
por: Assawasaksakul, Theerada, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6fcmlijoc959pnip25517brma